Executive Summary
Oncology/Anti-cancer drugs Market from Consainsights analyses the Oncology/Anti-cancer drugs Market in the Technology &
Media industry over the forecast period to 2026.
Oncology/Anti-cancer drugs research report from Consainsights outlines the detailed strategic analysis, trends,
market
opportunities, growth prospects, industry and market challenges and sustainable solutions to
sustain in the
competitive environment.
Oncology/Anti-cancer drugs segmentation includes Therapeutic Modalities, Cancer Types and Geography.
All segmentations encompasses the key innovations and
micro & macro trends, companies/manufacturers operating in this space along with their usage
and penetration
with respect to the wide range of End Users. Additionally, market sizing information along with
the key factors
such as market drivers, restraints, opportunities and challenges which are likely to be
influencing the market
growth are outlined in this report.
Based on the Therapeutic Modalities, the Oncology/Anti-cancer drugs Market analysis covers Chemotherapy, Hormonal therapy, Immunotherapy (biologics therapy), Others, Targeted therapy.
Based on the Cancer Types, the Oncology/Anti-cancer drugs Market analysis covers Blood cancer, Breast cancer, Gastrointestinal cancer, Other cancers, Prostate cancer, Respiratory/lung cancer, Skin cancer.
Key companies operating in the market include GlaxoSmithKline PLC, Sanofi, Roche Diagnostics, Amgen Inc., Merck & Company, AstraZeneca PLC., EIMC United Pharmaceuticals (EUP), Actavis plc, AbbVie Inc., Novartis AG and so on. This report
covers the detailed analysis of the company profiles
such as business segments, product portfolio, key brand insights and growth strategies adopted,
company SWOT and
Strategy analysis along with the financial analysis and analyst insights on the key companies
operating in this
market.
Moreover, the competitive analysis includes the companies deals such as Mergers, Acquisitions,
Partnerships and
so on along with the expansion areas focusing on the additional geographies, future insights for
success and
market share analysis. Major players strategies include the launch of the innovative product
lines along with
the emphasis on the partnerships and acquisitions to standardize their market share in the
market space.
Market Research methodology includes the triangulation of the data from the data sources such as
Primary Market
Research approach and Secondary Market Research Approach along with the data from the trade
bodies and industry
standard publications and data sources. Primary inputs from the industry experts and the market
respondents from
the respective industries to obtain very critical information to assess the future growth
prospects of the
market. The final data is triangulated and thoroughly validated considering all the data sources
using the
bottom-up and the top-down approaches to estimate the market sizing of the individual segments.
Report Metric
|
Details
|
Market size available for years
|
2012-2027
|
Base year considered
|
2021
|
Forecast period
|
2022-2027
|
Forecast units
|
Value (USD Billion)
|
Segments covered
|
Therapeutic Modalities, Cancer Types
|
Geographies covered
|
North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
|
Companies Covered
|
GlaxoSmithKline PLC, Sanofi, Roche Diagnostics, Amgen Inc., Merck & Company, AstraZeneca PLC., EIMC United Pharmaceuticals (EUP), Actavis plc, AbbVie Inc., Novartis AG
|
List of Figures & Tables
List of Figures
Figure: Global Oncology/Anti-cancer drugs Market: Structure
Figure: Global Oncology/Anti-cancer drugs Market: Value Chain Analysis
Figure: Global Oncology/Anti-cancer drugs Market: Porter's Five Forces Model
Figure: Global Oncology/Anti-cancer drugs Market: Market Dynamics
Figure: Global Oncology/Anti-cancer drugs Market, By Oncology/Anti-cancer drugs, 2022-2027 (USD Million)
Figure: North America Oncology/Anti-cancer drugs Market, By Oncology/Anti-cancer drugs, 2022-2027 (USD Million)
Figure: Europe Oncology/Anti-cancer drugs Market, By Oncology/Anti-cancer drugs, 2022-2027 (USD Million)
Figure: Asia-Pacific Oncology/Anti-cancer drugs Market, By Oncology/Anti-cancer drugs, 2022-2027 (USD Million)
Figure: Latin America Oncology/Anti-cancer drugs Market, By Oncology/Anti-cancer drugs, 2022-2027 (USD Million)
Figure: Middle East & Africa Oncology/Anti-cancer drugs Market, By Oncology/Anti-cancer drugs, 2022-2027 (USD Million)
Figure: Global Oncology/Anti-cancer drugs Market, By Oncology/Anti-cancer drugs, 2022-2027 (USD Million)
Figure: North America Oncology/Anti-cancer drugs Market, By Oncology/Anti-cancer drugs, 2022-2027 (USD Million)
Figure: Europe Oncology/Anti-cancer drugs Market, By Oncology/Anti-cancer drugs, 2022-2027 (USD Million)
Figure: Asia-Pacific Oncology/Anti-cancer drugs Market, By Oncology/Anti-cancer drugs, 2022-2027 (USD Million)
Figure: Latin America Oncology/Anti-cancer drugs Market, By Oncology/Anti-cancer drugs, 2022-2027 (USD Million)
Figure: Middle East & Africa Oncology/Anti-cancer drugs Market, By Oncology/Anti-cancer drugs, 2022-2027 (USD Million)
List of Tables
Table: Global Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2017-2026 (USD Million)
Table: North America Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)
Table: United States Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)
Table: Canada Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)
Table: Europe Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)
Table: Germany Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)
Table: United Kingdom Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)
Table: France Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)
Table: Spain Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)
Table: Russia Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)
Table: Italy Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)
Table: Rest of Europe Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)
Table: Asia-Pacific Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)
Table: China Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)
Table: Japan Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)
Table: India Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)
Table: Southeast Asia Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)
Table: Australia & New Zealand Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)
Table: Rest of Asia-Pacific Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)
Table: Latin America Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)
Table: Brazil Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)
Table: Argentina Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)
Table: Mexico Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)
Table: Colombia Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)
Table: Rest of Latin America Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)
Table: Middle East & Africa Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)
Table: Middle East Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)
Table: Africa Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)
Table: Rest of Middle East & Africa Oncology/Anti-cancer drugs Market, By Therapeutic Modalities, 2022-2027 (USD Million)
Table: Global Oncology/Anti-cancer drugs Market, By Cancer Types, 2017-2026 (USD Million)
Table: North America Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)
Table: United States Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)
Table: Canada Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)
Table: Europe Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)
Table: Germany Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)
Table: United Kingdom Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)
Table: France Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)
Table: Spain Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)
Table: Russia Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)
Table: Italy Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)
Table: Rest of Europe Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)
Table: Asia-Pacific Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)
Table: China Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)
Table: Japan Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)
Table: India Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)
Table: Southeast Asia Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)
Table: Australia & New Zealand Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)
Table: Rest of Asia-Pacific Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)
Table: Latin America Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)
Table: Brazil Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)
Table: Argentina Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)
Table: Mexico Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)
Table: Colombia Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)
Table: Rest of Latin America Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)
Table: Middle East & Africa Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)
Table: Middle East Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)
Table: Africa Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)
Table: Rest of Middle East & Africa Oncology/Anti-cancer drugs Market, By Cancer Types, 2022-2027 (USD Million)